Phosphodiesterase type 5 (PDE5) inhibitor

  • Sexual dysfunction Male
  • Avoid in heart disease
  • Female sexual dys on antidep
  • Long duration of action

Dosing

20mg 1/4-1/2 q36hr prn

Management

Caution in cardiac disease (interaction with nitrates, hypotension). Also treats Benign Prostatic Hypertrophy (BPH). If patient has heart disease, best to get cardiology approval or defer to PCP/cardiology to prescribe.

Best choice for sexual dys in men (and women on SSRIs) because long-duration allows spontaneity.

EMR Text

Diagnosis1

StartText1

WarningText1

Diagnosis2

StartText2

WarningText2

Scroll to Top